Clinical trial

Comparison Between Pioglitazone and SES With type2 DM

NCT00482183

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-07-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2003-07-01Date precision: month

Registry last updated2007-06-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Coronary Artery Diseaseunresolved

Type 2 Diabetes Mellitusunresolved

Interventions

PioglitazoneDRUG · verified · RxNorm: pioglitazone

Sponsors & collaborators

Showa Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00482183 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.